ORASURE TECHNOLOGIES INC OSUR

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $3.84
Market Cap $276.77M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-38.1% YoY
$115.02M
3-Yr CAGR: -33.3%
Net Income ↓-252.5% YoY
-$68.73M
Net Margin: -59.8%
Free Cash Flow ↓-325.7% YoY
-$53.22M
FCF Yield: -19.23%
EPS (Diluted) ↓-261.5% YoY
$-0.94
Basic: $-0.94
Return on Equity Efficiency
-20.2%
ROA: -26.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (OSUR)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $128.2M $88.0M $19.7M $0.35 $22.8M $18.4M
FY 2017 $167.1M +30.3% $99.0M $30.9M +56.9% $0.51 +45.7% $28.2M $23.8M +29.4%
FY 2018 $181.7M +8.8% $113.6M $20.4M -34.1% $0.33 -35.3% $39.1M $32.7M +37.5%
FY 2019 $154.6M -14.9% $94.6M $16.7M -18.3% $0.27 -18.2% $9.8M $0.5M -98.5%
FY 2020 $171.7M +11.1% $101.9M $-14.9M -189.6% $-0.22 -181.5% $5.8M $-20.9M -4,358.6%
FY 2021 $233.7M +36.1% $117.6M $-23.0M -54.1% $-0.32 -45.5% $-35.4M $-72.0M -245.1%
FY 2022 $387.5M +65.8% $147.6M $-17.9M +22.0% $-0.25 +21.9% $-47.2M $-54.0M +25.0%
FY 2023 $405.5M +4.6% $171.7M $53.7M +399.2% $0.72 +388.0% $141.6M $135.8M +351.6%
FY 2024 $185.8M -54.2% $79.4M $-19.5M -136.3% $-0.26 -136.1% $27.4M $23.6M -82.6%
FY 2025 $115.0M -38.1% $48.2M $-68.7M -252.5% $-0.94 -261.5% $-49.0M $-53.2M -325.7%
$

Valuation

Market Price $3.84
Market Cap $276.77M
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 0.78
FCF Yield -19.23%
Dividend Yield N/A
Shares Outstanding 68,848,600
%

Profitability & Margins

Gross Margin 41.90%
Operating Margin -62.57%
Net Margin -59.76%
Return on Equity (ROE) -20.17%
Return on Assets (ROA) -26.24%
Asset Turnover 0.44x
Revenue 3-Yr CAGR -33.29%
🛡️

Financial Health & Liquidity

Current Ratio 23.49
Cash Ratio 17.87
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $199.28M
Total Debt N/A
Book Value / Share $4.95
💧

Cash Flow Efficiency

Operating Cash Flow -$49.02M
Capital Expenditures (CapEx) $4.20M
Free Cash Flow -$53.22M
OCF / Revenue -42.62%
FCF / Revenue -46.27%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.94
EPS (Basic) $-0.94
Dividends / Share N/A
Book Value / Share $4.95
EPS YoY Growth -261.54%
🏛️

Balance Sheet (FY 2025)

Total Assets $261.91M
Total Liabilities $11.15M
Stockholders' Equity $340.83M
Current Assets $261.91M
Current Liabilities $11.15M